Bluecrest Capital Management LTD Has Decreased Extended Stay Amer (STAY) Stake By $8.36 Million; Ophthotech (OPHT)’s Sentiment Is 0.7

February 21, 2018 - By Migdalia James

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. The company has market cap of $98.75 million. The Company’s principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration . It has a 1.71 P/E ratio. The firm is also developing Zimura, an inhibitor of complement factor C5, for the treatment of dry AMD and wet AMD.

Bluecrest Capital Management Ltd decreased Extended Stay Amer Inc (STAY) stake by 94.73% reported in 2017Q3 SEC filing. Bluecrest Capital Management Ltd sold 440,217 shares as Extended Stay Amer Inc (STAY)’s stock rose 2.18%. The Bluecrest Capital Management Ltd holds 24,468 shares with $489,000 value, down from 464,685 last quarter. Extended Stay Amer Inc now has $3.69 billion valuation. The stock decreased 0.98% or $0.19 during the last trading session, reaching $19.19. About 1.45M shares traded. Extended Stay America, Inc. (NYSE:STAY) has risen 30.00% since February 21, 2017 and is uptrending. It has outperformed by 13.30% the S&P500.

Analysts await Ophthotech Corporation (NASDAQ:OPHT) to report earnings on February, 27. They expect $-0.58 EPS, up 68.82% or $1.28 from last year’s $-1.86 per share. After $5.25 actual EPS reported by Ophthotech Corporation for the previous quarter, Wall Street now forecasts -111.05% negative EPS growth.

The stock increased 1.86% or $0.05 during the last trading session, reaching $2.74. About 170,010 shares traded. Ophthotech Corporation (OPHT) has declined 94.82% since February 21, 2017 and is downtrending. It has underperformed by 111.52% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 8 selling transactions for $108,250 activity.

Armistice Capital Llc holds 1.12% of its portfolio in Ophthotech Corporation for 3.36 million shares. Bogle Investment Management L P De owns 448,841 shares or 0.09% of their US portfolio. Moreover, Dafna Capital Management Llc has 0.09% invested in the company for 50,000 shares. The California-based Regents Of The University Of California has invested 0.09% in the stock. Nine Chapters Capital Management Llc, a New Jersey-based fund reported 13,500 shares.

Ratings analysis reveals 0 of Ophthotech’s analysts are positive. Out of 6 Wall Street analysts rating Ophthotech, 0 give it “Buy”, 0 “Sell” rating, while 6 recommend “Hold”. OPHT was included in 6 notes of analysts from December 12, 2016. The rating was downgraded by Citigroup to “Neutral” on Monday, December 12. On Monday, December 12 the stock rating was downgraded by JP Morgan to “Neutral”. Chardan Capital Markets downgraded Ophthotech Corporation (NASDAQ:OPHT) rating on Monday, December 12. Chardan Capital Markets has “Neutral” rating and $15.0 target. The stock has “Mkt Perform” rating by Leerink Swann on Monday, December 12. The company was downgraded on Tuesday, December 13 by Gabelli. Goldman Sachs upgraded Ophthotech Corporation (NASDAQ:OPHT) on Tuesday, December 13 to “Neutral” rating.

Among 13 analysts covering Extended Stay America (NYSE:STAY), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Extended Stay America had 31 analyst reports since August 3, 2015 according to SRatingsIntel. The company was maintained on Wednesday, April 12 by Stifel Nicolaus. J.P. Morgan upgraded the shares of STAY in report on Wednesday, December 13 to “Buy” rating. JP Morgan upgraded Extended Stay America, Inc. (NYSE:STAY) on Wednesday, December 13 to “Overweight” rating. The stock of Extended Stay America, Inc. (NYSE:STAY) earned “Buy” rating by Deutsche Bank on Friday, July 31. Deutsche Bank maintained it with “Buy” rating and $21 target in Wednesday, November 8 report. The rating was maintained by Stifel Nicolaus with “Buy” on Tuesday, December 19. On Wednesday, October 28 the stock rating was maintained by Deutsche Bank with “Buy”. As per Thursday, June 29, the company rating was maintained by Stifel Nicolaus. The rating was initiated by Goldman Sachs with “Neutral” on Monday, September 26. The firm has “Buy” rating given on Monday, January 8 by Robert W. Baird.

Investors sentiment decreased to 1.4 in 2017 Q3. Its down 0.86, from 2.26 in 2017Q2. It is negative, as 20 investors sold STAY shares while 66 reduced holdings. 35 funds opened positions while 85 raised stakes. 182.36 million shares or 0.38% more from 181.67 million shares in 2017Q2 were reported. Comerica Bancshares holds 921,741 shares or 0.13% of its portfolio. State Street holds 0% or 2.57 million shares. Three Peaks Mgmt Limited Liability holds 698,785 shares or 2.06% of its portfolio. Burgundy Asset Mgmt Ltd has 2.52M shares for 0.48% of their portfolio. Zimmer Prtn Ltd Partnership stated it has 2.03% of its portfolio in Extended Stay America, Inc. (NYSE:STAY). Voya Management Lc, Georgia-based fund reported 2.55 million shares. The New York-based Alliancebernstein Limited Partnership has invested 0% in Extended Stay America, Inc. (NYSE:STAY). The Illinois-based Driehaus Ltd Liability Company has invested 0.03% in Extended Stay America, Inc. (NYSE:STAY). Thompson Davis Incorporated holds 0.06% or 1,768 shares in its portfolio. Wasatch Inc holds 0.04% or 131,855 shares. Pub Employees Retirement Association Of Colorado invested in 6,020 shares or 0% of the stock. Moreover, Inv Counselors Of Maryland Limited has 0.83% invested in Extended Stay America, Inc. (NYSE:STAY) for 807,700 shares. Bnp Paribas Arbitrage accumulated 212,891 shares. Cohen Steers Incorporated reported 2.74 million shares. Point72 Asia (Hong Kong) Limited accumulated 453 shares.

Analysts await Extended Stay America, Inc. (NYSE:STAY) to report earnings on February, 27 before the open. They expect $0.17 EPS, down 15.00% or $0.03 from last year’s $0.2 per share. STAY’s profit will be $32.69 million for 28.22 P/E if the $0.17 EPS becomes a reality. After $0.35 actual EPS reported by Extended Stay America, Inc. for the previous quarter, Wall Street now forecasts -51.43% negative EPS growth.

Bluecrest Capital Management Ltd increased Nike Inc (NYSE:NKE) stake by 6,190 shares to 13,031 valued at $676,000 in 2017Q3. It also upped Prudential Finl Inc (NYSE:PRU) stake by 81,193 shares and now owns 95,461 shares. Regions Finl Corp New (NYSE:RF) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: